Premium
Letter: immunogenicity of infliximab originator vs. CT ‐P13 in IBD patients
Author(s) -
Fiorino G.,
Correale C.,
Radice S.,
Allocca M.,
Furfaro F.,
Gilardi D.,
Nagore D.,
Del Rio L.,
Pascual J.,
Martínez A.,
Danese S.
Publication year - 2017
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.14262
Subject(s) - infliximab , medicine , immunogenicity , biosimilar , immunology , tumor necrosis factor alpha , antibody